A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors.

Naing, Aung

A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. [electronic resource] - Investigational new drugs Feb 2012 - 327-34 p. digital

Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1573-0646

10.1007/s10637-010-9536-x doi


Administration, Oral
Adult
Aged
Angiogenesis Inhibitors--administration & dosage
Anilides--administration & dosage
Area Under Curve
Biological Availability
Capsules
Chemistry, Pharmaceutical
Cross-Over Studies
Diphosphates--administration & dosage
Drug Compounding
Female
Humans
Least-Squares Analysis
Male
Middle Aged
Neoplasms--drug therapy
Protein Kinase Inhibitors--administration & dosage
Proto-Oncogene Proteins c-met--antagonists & inhibitors
Quinolines--administration & dosage
Tablets
Treatment Outcome
Young Adult